These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24899031)

  • 21. OXA-23 and ISAba1-OXA-66 class D β-lactamases in Acinetobacter baumannii isolates from companion animals.
    Ewers C; Klotz P; Leidner U; Stamm I; Prenger-Berninghoff E; Göttig S; Semmler T; Scheufen S
    Int J Antimicrob Agents; 2017 Jan; 49(1):37-44. PubMed ID: 27890443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of multidrug-resistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000-09).
    Gogou V; Pournaras S; Giannouli M; Voulgari E; Piperaki ET; Zarrilli R; Tsakris A
    J Antimicrob Chemother; 2011 Dec; 66(12):2767-72. PubMed ID: 21933784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme.
    Wisplinghoff H; Hippler C; Bartual SG; Haefs C; Stefanik D; Higgins PG; Seifert H
    Clin Microbiol Infect; 2008 Jul; 14(7):708-15. PubMed ID: 18558944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular epidemiology of Acinetobacter baumannii bloodstream isolates obtained in the United States from 1995 to 2004 using rep-PCR and multilocus sequence typing.
    Higgins PG; Janssen K; Fresen MM; Wisplinghoff H; Seifert H
    J Clin Microbiol; 2012 Nov; 50(11):3493-500. PubMed ID: 22895032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acinetobacter baumannii ST317 can be identified with Martins' trilocus sequence-based multiplex-PCR.
    Tavares LCB; de Vasconcellos FM; Sant'Ana DA; Tiba-Casas MR; Camargo CH
    Infect Genet Evol; 2018 Mar; 58():251-252. PubMed ID: 29331669
    [No Abstract]   [Full Text] [Related]  

  • 26. Molecular epidemiology of Acinetobacter baumannii in Iran: endemic and epidemic spread of multiresistant isolates.
    Hojabri Z; Pajand O; Bonura C; Aleo A; Giammanco A; Mammina C
    J Antimicrob Chemother; 2014 Sep; 69(9):2383-7. PubMed ID: 24562615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The emergence of a novel sequence type of MDR Acinetobacter baumannii from the intensive care unit of an Egyptian tertiary care hospital.
    Ghaith DM; Zafer MM; Al-Agamy MH; Alyamani EJ; Booq RY; Almoazzamy O
    Ann Clin Microbiol Antimicrob; 2017 May; 16(1):34. PubMed ID: 28486994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential of different molecular biology methods in tracking clones of Acinetobacter baumannii in an ICU setting.
    Ravi NS; Anandan S; Vijayakumar S; Gopi R; Lopes BS; Veeraraghavan B
    J Med Microbiol; 2018 Sep; 67(9):1340-1347. PubMed ID: 30016226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid molecular characterization of Acinetobacter baumannii clones with rep-PCR and evaluation of carbapenemase genes by new multiplex PCR in Hospital District of Helsinki and Uusimaa.
    Pasanen T; Koskela S; Mero S; Tarkka E; Tissari P; Vaara M; Kirveskari J
    PLoS One; 2014; 9(1):e85854. PubMed ID: 24465749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.
    Warner WA; Kuang SN; Hernandez R; Chong MC; Ewing PJ; Fleischer J; Meng J; Chu S; Terashita D; English L; Chen W; Xu HH
    BMC Infect Dis; 2016 May; 16():194. PubMed ID: 27146090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular epidemiology, antimicrobial susceptibility and carbapenemase resistance determinants among Acinetobacter baumannii clinical isolates in Taiwan.
    Chuang YC; Sheng WH; Lauderdale TL; Li SY; Wang JT; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2014 Aug; 47(4):324-32. PubMed ID: 23726465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High prevalence of the PER-1 gene among carbapenem-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia.
    Aly MM; Abu Alsoud NM; Elrobh MS; Al Johani SM; Balkhy HH
    Eur J Clin Microbiol Infect Dis; 2016 Nov; 35(11):1759-1766. PubMed ID: 27527351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy.
    Mezzatesta ML; D'Andrea MM; Migliavacca R; Giani T; Gona F; Nucleo E; Fugazza G; Pagani L; Rossolini GM; Stefani S
    Clin Microbiol Infect; 2012 Feb; 18(2):160-6. PubMed ID: 21722261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imported and intensive care unit-born Acinetobacter baumannii clonal complexes: one-year prospective cohort study in intensive care patients.
    Martins N; Martins IS; de Freitas WV; de Matos JA; Girão VB; Coelho-Souza T; Maralhães AC; Cacci LC; de Figueiredo MP; Dias RC; Costa-Lourenço AP; Ferreira AL; Dalla-Costa L; Nouér SA; Santoro-Lopes G; Riley LW; Moreira BM
    Microb Drug Resist; 2013 Jun; 19(3):216-23. PubMed ID: 23336529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Head-to-Head Comparison of Two Multi-Locus Sequence Typing (MLST) Schemes for Characterization of Acinetobacter baumannii Outbreak and Sporadic Isolates.
    Tomaschek F; Higgins PG; Stefanik D; Wisplinghoff H; Seifert H
    PLoS One; 2016; 11(4):e0153014. PubMed ID: 27071077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergence of extensively drug-resistant international clone IC-6 Acinetobacter baumannii carrying bla
    Fonseca ÉL; Caldart RV; Freitas FS; Morgado SM; Rocha LT; Dos Santos RC; Vicente ACP
    J Glob Antimicrob Resist; 2020 Mar; 20():18-21. PubMed ID: 31252155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
    Ganjo AR; Maghdid DM; Mansoor IY; Kok DJ; Severin JA; Verbrugh HA; Kreft D; Fatah MH; Alnakshabandi AA; Dlnya A; Hammerum AM; Ng K; Goessens W
    Microb Drug Resist; 2016 Dec; 22(8):627-637. PubMed ID: 27003287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality.
    Li YJ; Pan CZ; Fang CQ; Zhao ZX; Chen HL; Guo PH; Zhao ZW
    BMC Infect Dis; 2017 May; 17(1):371. PubMed ID: 28558660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extrahuman epidemiology of Acinetobacter baumannii in Lebanon.
    Rafei R; Hamze M; Pailhoriès H; Eveillard M; Marsollier L; Joly-Guillou ML; Dabboussi F; Kempf M
    Appl Environ Microbiol; 2015 Apr; 81(7):2359-67. PubMed ID: 25616788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.